---
figid: PMC6286919__tgh-03-2018.10.16-f1
figtitle: Schematic representation illustrating the signaling molecules that regulate
  the PD-1/PD-L1 transcription
organisms:
- NA
pmcid: PMC6286919
filename: tgh-03-2018.10.16-f1.jpg
figlink: /pmc/articles/PMC6286919/figure/f1/
number: F1
caption: A schematic representation illustrating the signaling molecules that regulate
  the PD-1/PD-L1 transcription. 1) Co-stimulation via CD28 in combination with the
  TCR modulates the activation of different cascades, for example, the Ras/MEK/ERK
  pathway and PI3K/AKT pathway, resulting in PD-1 transcriptional upregulation ().
  2) Expression of PD-L1 of tumor cells is (i) mediated by oncogenic activation of
  signaling pathways and can also be (ii) regulated by inflammatory molecules produced
  by effector immune cells, i.e., T cell in the tumor microenvironment. AKT, protein
  kinase B; APC, antigen presenting cell; ERK, extracellular signal-regulated kinase;
  IFNGR, interferon-gamma receptor; IFN-γ, interferon-gamma; IRF-1, interferon regulatory
  factor-1; JAK, janus tyrosine kinase; MEK, mitogen-activated protein kinase; MHC,
  major histocompatibility complex; NF-κB, nuclear factor kappa-light-chain-enhancer
  of activated B cells; PD-1, programmed cell death protein 1; PD-L1, programmed death-ligand
  1; PI3K, phosphatidylinositol-3 kinase, PKC8, protein kinase C; PTEN, phosphatase
  and tensin homolog; SHP2, src homology 2 phosphatase 2; STAT, signal transducer
  and activator of transcription, TCR, T cell receptor.
papertitle: 'Treatment of advanced hepatocellular carcinoma: immunotherapy from checkpoint
  blockade to potential of cellular treatment.'
reftext: Elaine Hon-Lam Siu, et al. Transl Gastroenterol Hepatol. 2018;3:89.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9465492
figid_alias: PMC6286919__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6286919__F1
ndex: 084b0e3d-defd-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6286919__tgh-03-2018.10.16-f1.html
  '@type': Dataset
  description: A schematic representation illustrating the signaling molecules that
    regulate the PD-1/PD-L1 transcription. 1) Co-stimulation via CD28 in combination
    with the TCR modulates the activation of different cascades, for example, the
    Ras/MEK/ERK pathway and PI3K/AKT pathway, resulting in PD-1 transcriptional upregulation
    (). 2) Expression of PD-L1 of tumor cells is (i) mediated by oncogenic activation
    of signaling pathways and can also be (ii) regulated by inflammatory molecules
    produced by effector immune cells, i.e., T cell in the tumor microenvironment.
    AKT, protein kinase B; APC, antigen presenting cell; ERK, extracellular signal-regulated
    kinase; IFNGR, interferon-gamma receptor; IFN-γ, interferon-gamma; IRF-1, interferon
    regulatory factor-1; JAK, janus tyrosine kinase; MEK, mitogen-activated protein
    kinase; MHC, major histocompatibility complex; NF-κB, nuclear factor kappa-light-chain-enhancer
    of activated B cells; PD-1, programmed cell death protein 1; PD-L1, programmed
    death-ligand 1; PI3K, phosphatidylinositol-3 kinase, PKC8, protein kinase C; PTEN,
    phosphatase and tensin homolog; SHP2, src homology 2 phosphatase 2; STAT, signal
    transducer and activator of transcription, TCR, T cell receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - APC
  - PROC
  - HLA-C
  - CD86
  - CD80
  - CD28
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PTPN11
  - NFKB1
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD274
  - PTEN
  - STAT3
  - IRF1
  - JAK1
  - IFNGR1
  - TCR
  - ARS
  - Cytotoxic
---
